These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3097675)

  • 1. Induction of ovulation in polycystic ovarian disease.
    Fleming R
    Prog Clin Biol Res; 1986; 225():401-12. PubMed ID: 3097675
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.
    Armitage M; Wilkin T; Dewbury K
    Br Med J (Clin Res Ed); 1987 Jul; 295(6590):96. PubMed ID: 3113653
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined gonadotropin-releasing hormone analog and exogenous gonadotropins for ovulation induction in infertile women: efficacy related to ovarian function assessment.
    Fleming R; Haxton MJ; Hamilton MP; Conaghan CJ; Black WP; Yates RW; Coutts JR
    Am J Obstet Gynecol; 1988 Aug; 159(2):376-81. PubMed ID: 3136650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The additional use of buserelin in HMG-HCG ovulation induction in PCO: a double blind controlled study.
    Hompes PG; van Weissenbruch MM; Burger CW; Schoemaker J
    Prog Clin Biol Res; 1986; 225():391-9. PubMed ID: 3097674
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma estrogen monitoring of ovulation induction.
    Wu CH
    Obstet Gynecol; 1975 Sep; 46(3):294-8. PubMed ID: 1172219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of ovulation in the patient with polycystic ovarian disease.
    Blankstein J; Quigley MM
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):733-49. PubMed ID: 3143566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary.
    Venturoli S; Paradisi R; Fabbri R; Magrini O; Porcu E; Flamigni C
    Obstet Gynecol; 1984 Jan; 63(1):6-11. PubMed ID: 6419189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of ovulation in a thalassaemic patient.
    De Sanctis V; Vullo C; Negri P; Codemi L; Mollica G; Bagni B
    Acta Eur Fertil; 1989; 20(4):223-5. PubMed ID: 2519575
    [No Abstract]   [Full Text] [Related]  

  • 9. Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome.
    Emperaire JC; Ruffie A
    Hum Reprod; 1991 Apr; 6(4):506-10. PubMed ID: 1918298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of the ovarian hyperstimulation syndrome.
    Haning RV; Strawn EY; Nolten WE
    Obstet Gynecol; 1985 Aug; 66(2):220-4. PubMed ID: 3927208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring gonadotropin therapy.
    Caldwell BV
    J Reprod Med; 1989 Jan; 34(1 Suppl):95-9. PubMed ID: 2497249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of ovulation with gonadotropins in patients with polycystic ovarian syndrome.
    Caruso A; Lanzone A; Fulghesu AM; Guida C; Apa R; Andreani CL; Mancuso S
    Contrib Gynecol Obstet; 1991; 18():42-53. PubMed ID: 1935128
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of GnRH analogues in combination with exogenous gonadotropins in infertile women.
    Fleming R; Jamieson ME; Hamilton MP; Black WP; Macnaughton MC; Coutts JR
    Acta Endocrinol Suppl (Copenh); 1988; 288():77-84. PubMed ID: 3138869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of ovulation with various regimens of luteinizing hormone-releasing hormone administration.
    Gual C
    Basic Life Sci; 1974; 4(PART A):355-70. PubMed ID: 4614788
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of buserelin on the hormonal states in PCOD.
    Willemsen WN; Franssen AM; Rolland R; Vemer HM
    Prog Clin Biol Res; 1986; 225():377-89. PubMed ID: 3097673
    [No Abstract]   [Full Text] [Related]  

  • 16. Oocytes collected 60 hours after human chorionic gonadotropin administration from patients with polycystic ovary syndrome who underwent limited ovarian stimulation resulted in clinical pregnancies and the delivery of a healthy baby.
    El-Sheikh MM; Sehly N; Al Mesiry W; Fouad S
    Fertil Steril; 2005 Dec; 84(6):1758-61. PubMed ID: 16359985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Plasma oestradiol and progesterone estimations in the monitoring of the induction of ovulation by human menopausal gonadotrophin and human chorionic gonadotrophin.
    McGarrigle HH; Radwanska E; Little V; Swyer GI
    J Endocrinol; 1974 May; 61(2):LXXXI-LXXXII. PubMed ID: 4835931
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ovulation induction].
    Lunenfeld B
    Rev Fr Gynecol Obstet; 1985 Nov; 80(11):803-8. PubMed ID: 3937202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stimulation of ovarian function with gonadotropins following suppression of endogenous gonadotropin secretion by long-term infusion of the LHRH analog buserelin].
    Geisthövel F; Bliefert R; Geyer H; Breckwoldt M; Sandow J
    Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):240-5. PubMed ID: 3109997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in sterility therapy. Gonadotropin treatment, monitoring follicle maturation using real-time ultrasonics].
    Schmidt W; von Holst T
    Fortschr Med; 1981 Jul; 99(27-28):1080-6. PubMed ID: 6790397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.